Imricor Medical Systems 提交Navtrac与Navtrac-mr可控导引器寻求美国FDA 510(k)许可

美股速递
Jul 20

Imricor Medical Systems 已正式向美国食品药品监督管理局提交了其Navtrac与Navtrac-mr可控导引器,以寻求510(k)市场准入许可。这一步骤标志着该公司在推进其创新医疗设备商业化进程中的关键进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10